Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)

NCT03780959 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Rheumatoid Arthritis

Interventions

DRUG: Etanercept
DRUG: Placebo

Sponsor

Amgen